EGFR

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

EGFR
Apr 16, 2024, 20:18 | Blog
Save the Date for the 4th Annual “Living with EGFR-Mutant Lung Cancer” forum! - Dana Farber's EGFR-Mutant Lung Cancer Center
Quoting Dana Farber's EGFR-Mutant Lung Cancer Center on X/Twitter: "Save the Date: Register today for…
Apr 10, 2024, 08:56 | Career
Pasi Jänne was recently recognised with the ACS 2024 Medal of Honour Award - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Pasi Jänne, senior vice president for Translational…
Mar 31, 2024, 08:44 | Blog
UCLA Health Jonsson Comprehensive Cancer Center's presentation at the annual meeting of the American Association for Cancer Research (AACR)
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will discuss the latest breakthroughs and cutting-edge science…
Mar 26, 2024, 00:22 | Opinion
Wafik S. El-Deiry: WIN Consortium in cancer personalized medicine MTB had well over 30 participants
Wafik S. El-Deiry shared on LinkedIn: "Today’s WIN Consortium in cancer personalized medicine MTB had well…
Mar 4, 2024, 17:34 | Insight
Jill Feldman: The importance of focusing on the 3 P's when discussing treatment options after a patient experiences progression on targeted therapy
Jill Feldman, Co-Founder of EGFR Resisters, posted on LinkedIn: "It was an honor to collaborate…
Jan 16, 2024, 05:48 | Drugs
Stephen V Liu: Many updates in the 1.2024 National Comprehensive Cancer Network (NCCN) NSCLC guidelines
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 8, 2024, 14:37 | Blog
A 32-year-old lung cancer survivor, mother of 2 and oncology nurse practitioner - EGFR Resisters
EGFR Resisters shared a post on X/Twitter: "Meet Caroline, A 32-year-old lung cancer survivor, mother…
Sep 28, 2023, 19:02 | Blog
Joel Bervell: Messages like this are my reminder of how important it is to create content about healthcare disparities and how powerful spreading accurate information via social media can be.
May 14, 2023, 09:34 | Drugs
Amivantamab Shows Efficacy in Advanced NSCLC With EGFR Exon 20 Insertions - The ASCO Post
Quoting from ASCO Post, "Amivantamab-vmjw, an EGFR and MET bispecific monoclonal antibody, has demonstrated encouraging…
12
All: 109 Posts: 101 - 200
Special Coverage